ClinicalTrials.gov
ClinicalTrials.gov Menu

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00780663
Recruitment Status : Completed
First Posted : October 28, 2008
Last Update Posted : June 15, 2011
Sponsor:
Information provided by:
Cylene Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2010
  Actual Study Completion Date : March 2010